IMMUNOME INC (IMNM)

US45257U1088 - Common Stock

14.27  -0.39 (-2.66%)

After market: 14.5 +0.23 (+1.61%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
14.02M0.000.000.000.00
Operating Expenses
42.75M36.90M25.20M12.26M10.35M
Research and Development
22.93M23.11M14.11M7.49M8.82M
Selling, General, and Administrative Expenses
19.82M13.79M11.09M4.78M1.53M
Operating Income
-28.73M-36.90M-25.20M-12.26M-10.35M
Interest Income/Expense
2.72M10.00K-10.00K-5.58M-100.00K
Other Income/Expense
N/A0.00500.00KN/AN/A
Non Recurring Items
-80.80MN/AN/AN/AN/A
Income Before Taxes
-106.81M-36.90M-24.71M-17.84M-10.44M
Net Income
-106.81M-37.52M-24.71M-17.84M-10.44M
EBITDA
-28.27M-36.48M-24.44M-11.50M-9.73M
 
Per Share Data
EPS Diluted Total Ops
-5.38-3.09-2.14-1.67-1.13
Non GAAP EPS
N/A-3.09-2.16N/AN/A
 
Statistics
Profit Margin
-761.92%N/AN/AN/AN/A
Operating Profit Margin
-204.94%N/AN/AN/AN/A

All data in USD

Charts